Sensus Healthcare Inc (SRTSU, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Sensus Healthcare Inc is a manufacturer of superficial radiation therapy devices. The Company's products and services include SRT-100, SRT-100 Vision, and Sentinel service program. Sensus Healthcare Inc has a market cap of $53.770 million; its shares were traded at around $6.45 .
For the last quarter Sensus Healthcare Inc reported a revenue of $8.08 million, compared with the revenue of $6.47 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $26.4 million, an increase of 28.4% from last year. For the last five years Sensus Healthcare Inc had an average revenue growth rate of 28.5% a year. The Sensus Healthcare Inc had an operating margin of -7.59%, compared with the operating margin of -18.05% a year before. The 10-year historical median operating margin of Sensus Healthcare Inc is -2.45%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, Sensus Healthcare Inc has the cash and cash equivalents of $12.5 million, compared with $10.1 million in the previous year. The company had no long term debt, compared with $2.22 million in the previous year. Sensus Healthcare Inc has a financial strength rank of 7 (out of 10).
For the complete 20-year historical financial data of SRTSU, click here.
